NN
Nirav Nalinkumar Vyas
About Nirav Nalinkumar Vyas
Data last updated:
Nirav Nalinkumar Vyas is a Director at Amerise Pharmaceuticals Private Limited (since 2021), Designated Partner at Amerigen Life Sciences Llp (since 2021) and Designated Partner at Amuna Pharmaceuticals Llp (since 2020), and holds 1 more current directorship. The companies operate in Pharma and Chemicals. The largest current company by reported revenue is Amerise Pharmaceuticals Private Limited at ₹2.18 Cr (FY 2025). Earlier, Nirav Nalinkumar Vyas was a Director at Brichem Sciences Private Limited (2017–2018) and Director at Vidman Pharmaceuticals Private Limited (2017–2018) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Amerise Pharmaceuticals Private Limited U36900GJ2018PTC104672 | Director | 04 Sep 2021 | 2018 | ₹2.18 Cr (FY 2025) | Active |
 Amerigen Life Sciences Llp AAM-2013 | Designated Partner | 02 Jan 2021 | 2018 | Active | |
 Amuna Pharmaceuticals Llp AAN-1236 | Designated Partner | 16 Sep 2020 | 2018 | Active | |
| Avimn Pharmaceuticals Llp AAP-4882 | Designated Partner | 03 Jun 2019 | 2019 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Brichem Sciences Private Limited U24304GJ2016PTC094569 | Director | 30 Dec 2017 | 2016 | ₹91.35 Cr (FY 2025) | Active |
 Vidman Pharmaceuticals Private Limited U24110GJ2017PTC098605 | Director | 07 Aug 2017 | 2017 | ₹3.52 Cr (FY 2024) | Active |
 Apister Lifesciences Private Limited U24304GJ2017PTC097161 | Director | 12 Feb 2018 | 2017 | ₹73.56 Cr (FY 2025) | Active |
| Sumar Biotech Llp AAL-8744 | Designated Partner | 19 Mar 2018 | 2018 | ₹58.12 Cr (FY 2023) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nirav Nalinkumar Vyas
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jalpaben Niravkumar Vyas | 08074004 | Amerise Pharmaceuticals Private Limited , Amerigen Life Sciences Llp and 1 more | Director |
| Vipul Ramanlal Patel | 08470124 | Avimn Pharmaceuticals Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nirav Nalinkumar Vyas
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirav Nalinkumar Vyas
Nirav Nalinkumar Vyas currently holds 4 directorships: Amerise Pharmaceuticals Private Limited (Director, since 04 Sep 2021, revenue ₹2.18 Cr (FY 2025)); Amerigen Life Sciences Llp (Designated Partner, since 02 Jan 2021); Amuna Pharmaceuticals Llp (Designated Partner, since 16 Sep 2020); Avimn Pharmaceuticals Llp (Designated Partner, since 03 Jun 2019).
Nirav Nalinkumar Vyas was first appointed on 07 Aug 2017 as Director at Vidman Pharmaceuticals Private Limited. The most recent appointment on record is 04 Sep 2021 at Amerise Pharmaceuticals Private Limited.
Nirav Nalinkumar Vyas held 4 earlier board appointments: Brichem Sciences Private Limited (Director, 30 Dec 2017 to 29 Sep 2018); Vidman Pharmaceuticals Private Limited (Director, 07 Aug 2017 to 10 Aug 2018); Apister Lifesciences Private Limited (Director, 12 Feb 2018 to 05 Nov 2018); Sumar Biotech Llp (Designated Partner, 19 Mar 2018 to 16 Sep 2019).
The current boards of Nirav Nalinkumar Vyas's companies include Jalpaben Niravkumar Vyas (Amerise Pharmaceuticals Private Limited), Vipul Ramanlal Patel (Avimn Pharmaceuticals Llp).